Theralink Technologies, Inc. financial data

Industry
Pharmaceutical Preparations
Location
8000 Innovation Park, Dr, Baton Rouge, Baton Rouge, LA
State of incorporation
Nevada
Fiscal year end
September 30
Former names
OncBioMune Pharmaceuticals, Inc (to 9/22/2020), QUINT MEDIA INC. (to 8/6/2015), PediatRx Inc. (to 8/6/2013), Striker Energy Corp (to 12/28/2010)

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.1 % -82.3%
Debt-to-equity -104 % -0.98%
Return On Equity 27.7 % -91.3%
Return On Assets -627 % +63.7%
Operating Margin -1.25K % +46.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.15B shares 0%
Common Stock, Shares, Outstanding 6.15B shares 0%
Entity Public Float 2.5M USD -35.9%
Common Stock, Value, Issued 615K USD 0%
Weighted Average Number of Shares Outstanding, Basic 6.15B shares 0%
Weighted Average Number of Shares Outstanding, Diluted 6.15B shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 3.6K USD
Revenue from Contract with Customer, Excluding Assessed Tax 635K USD +16.8%
Cost of Revenue 168K USD -12.4%
General and Administrative Expense 1.56M USD -24.9%
Operating Income (Loss) -7.95M USD +38%
Nonoperating Income (Expense) -5.55M USD +84.1%
Net Income (Loss) Attributable to Parent -13.5M USD +71.7%
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Marketable Securities, Current 500 USD -70.6%
Accounts Receivable, after Allowance for Credit Loss, Current 45.8K USD -5.21%
Assets, Current 257K USD -81.4%
Property, Plant and Equipment, Net 410K USD -37.5%
Operating Lease, Right-of-Use Asset 1.09M USD -4.47%
Assets 1.78M USD -45.1%
Accounts Payable, Current 675K USD -23.2%
Employee-related Liabilities, Current 268K USD +28.9%
Accrued Liabilities, Current 309K USD +161%
Contract with Customer, Liability, Current 141K USD -20.2%
Liabilities, Current 57.8M USD +24.6%
Long-term Debt and Lease Obligation 250K USD
Operating Lease, Liability, Noncurrent 1.12M USD -2.86%
Liabilities 58.9M USD +23.9%
Retained Earnings (Accumulated Deficit) -113M USD -13.6%
Stockholders' Equity Attributable to Parent -57.1M USD -28.9%
Liabilities and Equity 1.78M USD -45.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -963K USD +45.8%
Net Cash Provided by (Used in) Financing Activities -10.9K USD -100%
Net Cash Provided by (Used in) Investing Activities -7.98K USD
Common Stock, Shares Authorized 100B shares 0%
Common Stock, Shares, Issued 6.15B shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -974K USD -232%
Interest Paid, Excluding Capitalized Interest, Operating Activities 22.7K USD +535%
Deferred Tax Assets, Valuation Allowance 15.4M USD +18.9%
Deferred Tax Assets, Gross 15.4M USD +18.9%
Operating Lease, Liability 1.15M USD -2.29%
Depreciation 46.3K USD -8.25%
Payments to Acquire Property, Plant, and Equipment 7.98K USD
Lessee, Operating Lease, Liability, to be Paid 1.9M USD -5.95%
Property, Plant and Equipment, Gross 969K USD -7.92%
Operating Lease, Liability, Current 32.9K USD +22.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 128K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One 124K USD 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 748K USD -11.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 132K USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 15.4M USD +18.9%
Preferred Stock, Shares Authorized 26.7K shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 136K USD -91%
Additional Paid in Capital 55.1M USD +1.26%
Preferred Stock, Shares Outstanding 1.04K shares -64.8%
Share-based Payment Arrangement, Expense 683K USD -93.2%
Interest Expense 4.55M USD +147%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%